Biz Redrawn for Treasury Access

Tags: gs, ms, axp, gnw, lnc, aeg
19 Nov 4:17am
Posted by ZacksResearch
0 Comments
Read original blog entry

It is really interesting to see how companies are finding ways to gain access to the TARP funds. Initially, the investment banks -- Goldman Sachs (GS) and Morgan Stanley MS) -- then credit card companies like American Express (AXP) converted themselves into bank holding companies, and now at least three U.S. insurance companies -- Hartford Financial Services (HIG), Genworth Financial (GNW) and Lincoln National (LNC) have applied to the Office of Thrift Supervision (OTS) to buy savings and loan companies in order to get capital infusions from the Treasury.

Dutch insurer Aegon NV (AEG) has also stated that it may buy a small U.S. thrift company to qualify for the capital infusion. We should not be surprised if the big three automakers convert themselves into bank holding companies to get a piece of the pie.

If the insurers become eligible to gain access to TARP, it would be a very handsome return for small investments.  For example, Hartford Financial has sought OTS approval to buy the savings and loan parent company of Federal Trust Bank for about $10 million and will spend some additional amount to recapitalize the bank. In exchange, HIG estimates that it will be eligible for a capital injection of between $1.1 billion and $3.4 billion. Further, the terms are extremely attractive in the current state of economy as the 5% coupon for five years under the Capital Purchase Program represents very cheap source of capital.

We do not know how the lawmakers will react to the proposal and whether the insurers will get a capital infusion from the government. If the purpose of the program is to stabilize the financial markets, then the insurers should be eligible to get the money since they are very important to the health of financial markets. But the insurers are competing with many other financial firms for a shrunk pie now, as only approximately $90 billion is left of $350 billion of bailout funds that are being used initially.

While we would view the capital infusion, if any, as positive for HIG, we remain concerned with the increasing losses on the investment portfolio and the variable annuity business and our rating on the shares remains unchanged at a Sell.



Get real-time market insights and profitable stock recommendations from the team of analysts at Zacks Equity Research. See all today’s Analyst Blog entries on Zacks.com.

Comments

Back to top

Post comment

Back to top

Post a comment

Please login to post a comment

About

ZacksResearch

Zacks Investment Research is one of the most highly regarded firms in the investment industry. Our firm has long believed that that quantitative models (like the Zacks Rank) can predict stock prices more accurately than individual analysts. However we also recognize that models are most effective when they are employed by analysts who have deep fundamental knowledge of the company and its industry. Consequently Zacks Equity Research combines Zacks quantitative models with the insight provided by an experienced team of 50 analysts to create superior long term stock recommendations. Discover all their timely insight and recommendations daily on Zacks.com.

Recent Entries